Unlocking the full potential of inhalation technologies and therapies

Senzer develops, manufactures and licences breakthrough respiratory products for the effective delivery of pharmaceutical cannabinoids

Breaking news

Senzer’s Respiratory Cannabinoid Device Notches Up Another Design Award

Read More

Unique respiratory cannabinoid delivery

Senzer is a pharmaceutical company which develops, manufactures and licences innovative respiratory devices for the safe and reliable delivery of pharmaceutical cannabinoids – systemic therapies that deliver acute, breakthrough and refractory treatment.

Cannabinoids have long been identified as promising treatment options for a range of conditions, including those associated with cancer treatment; however, the drawbacks of oral delivery have limited their uptake. Senzer’s breakthrough inhalation platform delivers cannabinoids with a fast onset of action and high bioavailability, providing a new safe and effective treatment option that can be easily self-administered. Our products can make a real and tangible difference to a patients quality of life by advancing the treatment options available.

At Senzer, we’re discovering new ways to make life better. From research and development through to commercialisation, we explore, innovate and modify our technologies to complement and enhance existing conventional and alternative treatments to ensure we are a leader in this field.

Recent News

Nov 22 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Respiratory Cannabinoid Device Notches Up Another Design Award

Senzer's pharmaceutical cannabinoid device has won another major design award, with the German Design Council commending the unique inhaler for having 'a clear modern design that perfectly combines ergonomics and functionality'.    The award is the third design success for Senzer's Class IIa Medical Device, which is breath-activated and delivers a precise dose of pharmaceutical cannabinoids, and has been used...

Read More
Sep 17 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Medical Device Approved in Europe for the Safe and Effective Delivery of Cannabinoids

Senzer Pharmaceuticals has been granted a CE Mark that certifies its inhaler as a medical device, allowing it to now be available for patients in Europe for the 'safe and effective delivery of pharmaceutical cannabinoids.' The Class IIa Medical Device approval is the first-ever in the cannabinoid space and clears the way for the UK-based Company to supply...

Read More
May 3 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer Closes UK Government Innovation Fund Credit Facility

Senzer is proud to announce it is the recipient of a credit facility from Innovate UK, the United Kingdom Government backed department that funds only a select number of business that can demonstrate extraordinary innovation and potential to the UK economy. After a rigorous application process, the facility was awarded to Senzer as part of...

Read More